Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Stefanie Schrauwen"'
Autor:
Hui Zhao, Bernard Thienpont, Betül Tuba Yesilyurt, Matthieu Moisse, Joke Reumers, Lieve Coenegrachts, Xavier Sagaert, Stefanie Schrauwen, Dominiek Smeets, Gert Matthijs, Stein Aerts, Jan Cools, Alex Metcalf, Amanda Spurdle, ANECS, Frederic Amant, Diether Lambrechts
Publikováno v:
eLife, Vol 3 (2014)
DNA replication errors that persist as mismatch mutations make up the molecular fingerprint of mismatch repair (MMR)-deficient tumors and convey them with resistance to standard therapy. Using whole-genome and whole-exome sequencing, we here confirm
Externí odkaz:
https://doaj.org/article/3686d089d2d84213816650f5cb0bc4ec
Autor:
Veerle Janssens, Anna Sablina, Etienne Waelkens, Frédéric Amant, Yana Hoorne, Stefanie Schrauwen, Antoine Hubert, Rita Derua, Layka Abbasi Asbagh, Dorien Haesen
Primary antibodies used in this study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b35b35f75686764f583e92fa527442d
https://doi.org/10.1158/0008-5472.22413375.v1
https://doi.org/10.1158/0008-5472.22413375.v1
Autor:
Veerle Janssens, Anna Sablina, Etienne Waelkens, Frédéric Amant, Yana Hoorne, Stefanie Schrauwen, Antoine Hubert, Rita Derua, Layka Abbasi Asbagh, Dorien Haesen
Supplemental Figure 1: Cellular binding assays in HEK293 cells, assessing binding of B55/B, B56/B' and PR72/B" subunits to endometrial cancer-associated Aα mutants. Supplemental Figure 2: Comparative analysis of binding of Aα mutants and endoge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37e859019850b82966863ff59b59eb23
https://doi.org/10.1158/0008-5472.22413384.v1
https://doi.org/10.1158/0008-5472.22413384.v1
Autor:
Veerle Janssens, Anna Sablina, Etienne Waelkens, Frédéric Amant, Yana Hoorne, Stefanie Schrauwen, Antoine Hubert, Rita Derua, Layka Abbasi Asbagh, Dorien Haesen
Supplementary Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dedbbbe6e6cd0ce9d4c69b812f794fcd
https://doi.org/10.1158/0008-5472.22413387.v1
https://doi.org/10.1158/0008-5472.22413387.v1
Autor:
Veerle Janssens, Anna Sablina, Etienne Waelkens, Frédéric Amant, Yana Hoorne, Stefanie Schrauwen, Antoine Hubert, Rita Derua, Layka Abbasi Asbagh, Dorien Haesen
Somatic missense mutations in the Ser/Thr protein phosphatase 2A (PP2A) Aα scaffold subunit gene PPP2R1A are among the few genomic alterations that occur frequently in serous endometrial carcinoma (EC) and carcinosarcoma, two clinically aggressive s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33dbb00a02b664035625ff9c6edc8fc1
https://doi.org/10.1158/0008-5472.c.6508701.v1
https://doi.org/10.1158/0008-5472.c.6508701.v1
Autor:
Peter Bronsert, Eva Colas, M Koskas, Marc Hirschfeld, Reidun K. Kopperud, Maria Santacana, Louis J.M. van der Putten, F. Alameda, Jutta Huvila, Leon F.A.G. Massuger, Frédéric Amant, Johan Bulten, Lubos Minar, Saskia van den Berg-van Erp, Marc P.L.M. Snijders, Antonio Gil-Moreno, Johanna M.A. Pijnenborg, Koen Van de Vijver, Francine Walker, Gemma Mancebo, Helga B. Salvesen, Vít Weinberger, Eva Jandáková, Henrica M.J. Werner, Stefanie Schrauwen, Xavier Matias-Guiu, Angel Garcia, Jone Trovik, Nicole C.M. Visser
Publikováno v:
International Journal of Gynecological Cancer, 28, 3, pp. 514-523
International journal of gynecological cancer, 28(3), 514-523. Wolters Kluwer Health
International Journal of Gynecological Cancer, 28, 514-523
International journal of gynecological cancer, 28(3), 514-523. Wolters Kluwer Health
International Journal of Gynecological Cancer, 28, 514-523
ObjectivesEndometrial carcinoma mortality is mainly caused by recurrent disease, and various immunohistochemical markers to predict recurrences have been studied. Loss of the estrogen receptor (ER) and progesterone receptor (PR) and the presence of t
Autor:
Takahiro Kinoshita, Florian Lordick, Takaki Yoshikawa, Kozo Kataoka, Michel Ducreux, Anna Dorothea Wagner, Masanori Terashima, Murielle Mauer, Masanori Tokunaga, Stefanie Schrauwen, Markus Moehler, Narikazu Boku, Kohei Shitara, Franco Roviello
Publikováno v:
Gastric Cancer. 20:904-912
The role of multidisciplinary treatment including surgery for liver metastases from gastric cancer (LMGC) is controversial. Studies to answer this clinical question are increasing in number, but all published data thus far are based on retrospective
Autor:
Rita Derua, Antoine Hubert, Layka Abbasi Asbagh, Stefanie Schrauwen, Yana Hoorne, Veerle Janssens, Anna Sablina, Frédéric Amant, Dorien Haesen, Etienne Waelkens
Publikováno v:
Cancer research, 76(19), 5719-5731. American Association for Cancer Research Inc.
Somatic missense mutations in the Ser/Thr protein phosphatase 2A (PP2A) Aα scaffold subunit gene PPP2R1A are among the few genomic alterations that occur frequently in serous endometrial carcinoma (EC) and carcinosarcoma, two clinically aggressive s
Autor:
Ilse Gutierrez-Roelens, Els Hermans, Jeroen Depreeuw, Philippe Moerman, Katrien Konings, David Debruyne, Mathieu Luyckx, Daniela Annibali, Ignace Vergote, Diether Lambrechts, Debby Thomas, Stefanie Schrauwen, Frédéric Amant, Lieve Coenegrachts
Publikováno v:
Gynecologic oncology, 139(1), 118-126. Academic Press Inc.
Gynecologic Oncology, Vol. 139, no. 1, p. 118-126 (2015)
Gynecologic Oncology, Vol. 139, no. 1, p. 118-126 (2015)
Objective. Endometrial carcinoma (EC) is the sixth most common cancer in women and therapies are limited for advanced and recurrent disease. Patient-derived tumor xenograft (PDTX) models are becoming popular tools in translational research because of
Autor:
Stefanie Schrauwen, Frédéric Amant, Diether Lambrechts, Anna Cattaneo, Lieve Coenegrachts, Els Hermans
Publikováno v:
Gynecologic oncology, 138(2), 378-382. Academic Press Inc.
Objectives. New treatment options for advanced and recurrent endometrial carcinoma (EC) are necessary. Epidemiological studies showed that diabetic patients using metformin have reduced risks of endometrial cancer (EC) incidence. Moreover, pre- and c